Neonatal lupus with left bundle branch block and cardiomyopathy: a case report

Abstract

Background Cardiac manifestations of neonatal lupus include an array of structural and conduction abnormalities due to placental transference of maternal anti-SSA/Ro and anti-SSB/La autoantibodies. Late-onset neonatal lupus cardiomyopathies, occurring outside the neonatal period, is an infrequently reported manifestation with unknown pathophysiology and poorly defined treatment regimens. Due to the rarity of this condition, additional studies and case reports are required to better understand and manage late-onset neonatal lupus cardiomyopathies. Case presentation A 4-week-old female, born to a mother with known anti-SSA/Ro and anti-SSB/La autoantibodies, presents with classic cutaneous manifestations for neonatal lupus and is found to have left bundle branch block, severely dilated cardiomyopathy with an ejection fraction of 25%, and a thin echogenic dyskinetic ventricular septum. Weekly second trimester and 30-week fetal echocardiograms showed no signs of structural or conduction abnormalities. There were no histologic signs of inflammation on cardiac tissue biopsy. After a complicated hospital course, she was successfully treated with biventricular pacemaker, intravenous immunoglobulin, and plasmapheresis. Conclusions We present a case of late-onset neonatal lupus with severe dilated cardiomyopathy, a dyskinetic ventricular septum, and left bundle branch block. To our knowledge, the dyskinetic ventricular septum has never been reported and left bundle branch block is rarely reported in NL. This case further validates the need for long term cardiac follow up for patients born with NL, even if lacking cardiac manifestations in the peripartum period. We characterize a unique presentation of a rare clinical entity, highlighting the diagnostic challenges, and describe a successful treatment course.

Neonatal lupus: diagnostic difficulties, treatment and prognosis in an extremely premature baby

“…У пациентов с АВ-блокадой II и III степени может отмечаться субклиническое повреждение миокарда в неонатальном периоде, что делает его более восприимчивым к поражению в результате длительного функционирования кардиостимуляторов. Пациенты с ВБС также имеют повышенный риск развития инсультов, инфекционных заболеваний и системных болезней соединительной ткани [39,42].…”

“…Вопрос о постнатальном ведении пациентов с поражением сердца вследствие НВ остается крайне дискутабельным [42][43][44]. В связи с небольшим количеством зарегистрированных пациентов разработка единых алгоритмов обследования и лечения не представляется возможной.…”